Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone
Authors:
- 1 May 2025
- journal article
- Published by Elsevier in European Journal of Radiology
- Vol. 188, 112152
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30 CA008748)
This publication has 41 references indexed in Scilit:
- Development of the ‘PREDICT’ score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excisionUpdates in Surgery, 2020
- Can CRM Status on MRI Predict Survival in Rectal Cancers: Experience from the Indian SubcontinentIndian Journal of Surgical Oncology, 2019
- Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patternsInternational Journal of Clinical Oncology, 2019
- Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node MetastasesWorld Journal of Surgery, 2016
- Impact of multimodal therapy in locally recurrent rectal cancerBritish Journal of Surgery, 2016
- Pattern of rectal cancer recurrence after curative surgeryInternational Journal of Colorectal Disease, 2015
- Factors Associated with Local Recurrence After Neoadjuvant Chemoradiation with Total Mesorectal Excision for Rectal CancerWorld Journal of Surgery, 2009
- Local recurrence after curative resection in patients with colon and rectal cancersInternational Journal of Colorectal Disease, 2008
- Extended Radical Resection: The Choice for Locally Recurrent Rectal CancerDiseases of the Colon & Rectum, 2008
- Local Recurrence following Total Mesorectal Excision with Double‐stapling Anastomosis for Rectal Cancers: Analysis of Risk FactorsWorld Journal of Surgery, 2002